Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Notice

NHS Pharmaceuticals 2016_2Offer reference number: CM/PHG/12/5379Period of framework agreement: Dates

  • First published: 19 July 2016
  • Last modified: 19 July 2016
  • Version: N/A
  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Information icon
You are viewing an expired notice.

Contents

Summary

OCID:
Published by:
Commercial Medicines Unit
Authority ID:
AA26502
Publication date:
19 July 2016
Deadline date:
17 August 2016
Notice type:
Contract Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

NHS Pharmaceuticals 2016_2

Offer reference number: CM/PHG/12/5379

Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 36 months

Potential periods of call-offs under the framework agreement:

North West & Eastern & North London: 1.1.2017 to 31.1.2018 (13 months)

South East & South London & North East & Yorkshire: 1.1.2017 to 30.6.2018 (18 months)

Central & South West: 1.1.2017 to 30.6.2017 (6 months).

Full notice text

CONTRACT NOTICE – OFFICIAL JOURNAL

Section I: Contracting Authority

I.1)

Name, Address and Contact Point(s)


The Secretary of State for Health acting as part of the Crown through the Commercial Medicines Unit (part of the Department of Health)

2nd Floor, Rutland House

Runcorn

WA7 2ES

UK

Blackman Sarah


sarah.blackman@dh.gsi.gov.uk


https://cmu.bravosolution.co.uk



https://cmu.bravosolution.co.uk

https://cmu.bravosolution.co.uk
Checked box
Unchecked box
Checked box
Unchecked box
Checked box
Unchecked box

I.2)

Type of contracting Authority and Main Activity or Activities

Checked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Checked box
Unchecked box
Unchecked box
Unchecked box
Unchecked box
Checked box
public procurement
Yes

Information is contained within the Invitation To Offer

Section II: Object of the Contract

II.1)

Description

II.1.1)

Title attributed to the contract by the contracting authority

NHS Pharmaceuticals 2016_2Offer reference number: CM/PHG/12/5379Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 36 monthsPotential periods of call-offs under the framework agreement:North West & Eastern & North London: 1.1.2017 to 31.1.2018 (13 months)South East & South London & North East & Yorkshire: 1.1.2017 to 30.6.2018 (18 months)Central & South West: 1.1.2017 to 30.6.2017 (6 months).

II.1.2(a))

Type of works contract

II.1.2(b))

Type of supplies contract

Checked box Unchecked box Unchecked box
Unchecked box Unchecked box

II.1.2(c))

Type of service contract

II.1.2)

Main site or location of works, place of delivery or performance

Main site or location of works, place of delivery or of performance: The framework agreement is intended for use by the Department of Health, Public Health England and the NHS in England. The framework may also be used by private sector contractors and agents working on behalf of the above. Please refer to Document 10 in the Invitation To Offer Documents for the list of Purchasing Points.



UK

II.1.3)

This notice involves

Unchecked box
Unchecked box
Checked box

II.1.4)

Information on framework agreement (if applicable)

Unchecked box
Checked box

Number of participants to the framework agreement envisaged

Duration of the framework agreement

Justification for a framework agreement the duration of which exceeds four years

Estimated total value of purchases for the entire duration of the framework agreement

210 000 000230 000 000GBP

Frequency and value of the contracts to be awarded

II.1.5)

Short description of the contract or purchase(s)

NHS Pharmaceuticals 2016_2

Offer reference number: CM/PHG/12/5379

Period of framework agreement: Dates detailed below with options to extend up to a maximum period of 36 months

Potential periods of call-offs under the framework agreement:

North West & Eastern & North London: 1.1.2017 to 31.1.2018 (13 months)

South East & South London & North East & Yorkshire: 1.1.2017 to 30.6.2018 (18 months)

Central & South West: 1.1.2017 to 30.6.2017 (6 months).

II.1.6)

Common Procurement Vocabulary (CPV)

33600000
33690000

II.1.7)

Contract covered by the Government Procurement Agreement (GPA)

Checked box

II.1.8)

Division into lots

Yes

Unchecked box Checked box Unchecked box

II.1.9)

Will variants be accepted

No

II.2)

Quantity or Scope of the Contract

II.2.1)

Total quantity or scope

Information regarding lots is contained within the Invitation To Offer — please refer to Document No. 02.

210 000 000230 000 000
GBP

II.2.2)

Options

This framework agreement has the option to extend for a period of up 36 months.

Provisional timetable for recourse to these options

Number of possible renewals

In the case of renewable supplies or service contracts, estimated time frame for subsequent contracts

II.3)

Duration of the contract or limit for completion

 1-1-2017 31-12-2019

Section III: Legal, Economic, Financial and Technical Information

III.1)

Conditions Relating to the Contract

III.1.1)

Deposits and guarantees required

Parent company or other guarantees may be required in certain circumstances.

III.1.2)

Main Terms of financing and payment and/or reference to the relevant provisions

Refer to the Price and Payment clauses contained within the Invitation To Offer, Document no.3, Conditions of Contract.

III.1.3)

Legal form to be taken by the grouping of suppliers, contractors or service providers to whom the contract is to be awarded

No special legal form is required but, if a contract is awarded to a consortium of economic operators, the members of that consortium may be required to form a legal entity before entering into a Framework Agreement and may be required to provide parent company or directors' guarantees or, if not required to form a legal entity, members of a consortium may be required to accept joint and several liability both to the Contracting Authority under the Framework Agreement and to other contracting authorities awarding contracts under the Framework Agreement.

III.1.4)

Other particular conditions to which the performance of the contract is subject

Refer to the Invitation To Offer, Document no.3, Conditions of Contract.

III.2)

Conditions for Participation

III.2.1)

Personal situation of economic operators, including requirements relating to enrolment on professional or trade registers


Responding To This Notice;

Any supplier may be disqualified who does not respond to the following in the requisite manner:

1) Submission of expression of interest and procurement specific information

This procurement exercise will be conducted on the eTendering portal at www.cmu.bravosolution.co.uk. Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested), through the eTendering portal as follows:

1.1) If not already registered, Candidates should register on the eTendering portal at https://www.cmu.bravosolution.co.uk and click the link to register:

— accept the terms and conditions and click continue,

— enter your correct business and user details,

— note the username you chose and click ‘Save’ when complete,

— you will shortly receive an email with your unique password (please keep this secure).

1.2) Once registered, candidates must express interest as follows:

a. login to the eTendering portal;

b. select ‘Response to ITT’;

c. select ‘ITTs Open To All Suppliers’;

d. access listing related to this procurement NHS Pharmaceuticals 2016_2 and view details;

e. click on ‘Express interest’ button at the top of the page.

f. Once you have expressed interest, the ITT will move to ‘My ITTs’, where you can download additional documentation (if required), and construct your reply as instructed. You must then publish your reply using the ‘Publish’ button.

1.3) For any support in registering on the portal or submitting your expression of interest please contact the eTendering Help-desk at +44 800 368 4850 or help@bravosolution.co.uk.

2) General supplier information.

To manage and assess supplier information the Contracting Authority requests candidates provide their company profile in the Governments supplier information database, sid4gov, as follows:

2.1) If not already registered, Candidates must go to the following web page https://sid4gov.cabinetoffice.gov.uk/ and select ‘Register for sid4gov’ at the bottom of the page. Key in details as requested to search for your company. If you do not have a D-U-N-S® Number, click on the link at the right of the page to obtain a number from D&B. Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S® Number to enable registration on sid4gov.

2.2) Once registration is complete you are able to create and update your sid4gov company profile. Candidates should ensure all the mandatory fields of their sid4gov profile are completed and up to date for each procurement exercise. D&B data will be supplied automatically by D&B.

2.3) For further help or information concerning sid4gov, please contact the sid4gov Helpdesk at: support@nqc.com or telephone +44 (0) 845 299 2994.

III.2.2)

Economic and financial capacity





III.2.3)

Technical capacity





III.2.4)

Reserved contracts

Unchecked box
Unchecked box

Section IV: Procedure

IV.1)

Type of Procedure


Checked box Unchecked box
Unchecked box Unchecked box
Unchecked box Unchecked box

Justification for the choice of accelerated procedure

IV.1.1)

Have candidates already been selected?

No

IV.1.2)

Limitations on the number of operators who will be invited to tender or to participate

Objective criteria for choosing the limited number of candidates

IV.1.3)

Reduction of the number of operators during the negotiation or dialogue

Unchecked box

IV.2)

Award Criteria

No


Yes

No

IV.2.2)

An electronic auction will be used

No

IV.3 Administrative Information

IV.3.1)

Reference number attributed to the notice by the contracting authority

CM/PHG/12/5379

IV.3.2)

Previous publication(s) concerning the same contract

Unchecked box
Unchecked box


Other previous publications

IV.3.3)

Conditions for obtaining specifications and additional documents



 


IV.3.4)

Time-limit for receipt of tenders or requests to participate

 17-08-2016  13:00

IV.3.5)

Date of dispatch of invitations to tender or to participate to selected candidates


IV.3.6)

Language or languages in which tenders or requests to participate can be drawn up

Checked box    

IV.3.7)

Minimum time frame during which the tenderer must maintain the tender 

IV.3.8)

Conditions for opening tenders



Commercial Medicine Unit Employee.



Section VI: Other Information

VI.1)

Indicate whether this procurement is a recurrent one and the Estimated timing for further notices to be published


VI.2)

Does the contract relate to a Project/Programme financed by Community Funds?

No



VI.3)

Additional Information

Other Contracting Authorities

The framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.

Where a framework agreement is concluded with a single economic operator, contracts based on that agreement shall be awarded within the limits of the terms laid down in the framework agreement.

For the award of those contracts, contracting authorities may consult the economic operator party to the framework agreement in writing, requesting it to supplement its tender as necessary.

Where a framework agreement is concluded with more than one economic operator, that framework agreement shall be performed by following the terms and conditions of the framework agreement, without reopening competition, where it sets out all the terms governing the provision of the works, services and supplies concerned and the objective conditions for determining which of the economic operators, party to the framework agreement, shall perform them; the latter conditions shall be indicated in the procurement documents for the framework agreement.

Electronic Ordering, Invoicing And/or Payment

a.Electronic Submission of Tenders or requests to participate will be required.

b. Some participating authorities may use electronic ordering. Some participating authorities may accept electronic invoicing.

Some participating authorities may use electronic payment

Transparency

Potential suppliers should note that, in accordance with the Government's policies on transparency, the Contracting Authority intends to publish the OJEU, ITO and the text of final contracts / framework agreements, subject to possible redactions at the discretion of the CMU (part of the Department of Health). Further information on transparency can be found at: https://www.gov.uk/government/policies/buying-and-managing-government-goods-and-services-more-efficiently-and-effectively.

Lot Description

CESW — Central, South Central and South West

LSNE — South East, South London, North East and Yorkshire

NWLN — Eastern, North London and North West

(as described in Doc 10 of the ITO

A detailed description of the goods and/or services that an Offeror will be required to supply for a Lot in which it has been successful is set out in the Offer Schedule (Doc 06a(ii) and the Specification (Doc 05).

Each National Product Code product Description listed in the Offer Schedule (Doc 06a(ii)), shall be a ‘Product’ for the purposes of this ITO

The tender comprises of the following offer schedule:

CM/PHG/12/5379/00

For each Product comprised in this offer schedule Offerors have the opportunity to bid for all (or any) of the 3 Lots specified in para 8.1 of Doc 02 of the ITO

To ensure a diverse range of suppliers, in respect of each Product listed in the Offer Schedule (Doc 06a(ii)) there is a restriction on the number of Lots that an Offeror can be awarded as follows:

Where 3 or more compliant offers that meet the qualitative criteria are received, a maximum of 1 Lot may be awarded to 1 supplier;

Where only 2 compliant offers that meet the qualitative criteria are received, a maximum of 2 Lots maybe awarded to 1 supplier;

Where only 1 compliant offer that meets the qualitative criteria is received, a maximum of all 3 Lots may be awarded to 1 supplier.

In respect of each Product in each Lot, unless otherwise notified, this procurement will establish a single supplier framework arrangement.

VI.4)

Procedures for appeal

VI.4.1)

Body responsible for appeal procedures










Body responsible for mediation procedures










VI.4.2)

Lodging of appeals

VI.4.3)

Service from which information about the lodging of appeals may be obtained










VI.5)

Dispatch date of this Notice

 13-07-2016

ANNEX B

Information About Lots

1     NHS Pharmaceuticals 2016_2

1)

Short Description

Dates detailed below with options to extend up to a maximum period of 36 months:

North West & Eastern & North London: 1.1.2017 to 31.1.2018 (13 months)

South East & South London & North East & Yorkshire: 1.1.2017 to 30.6.2018 (18 months)

Central & South West: 1.1.2017 to 30.6.2017 (6 months).

Requirement And Lot Structure

The procurement is sub-divided into Lots. For this procurement process there are three Lots made up of the following geographic buying groups:

Lot description

CESW — Central, South Central and South West

LSNE — South East, South London, North East and Yorkshire

LNNW — Eastern, North London and North West

(as more particularly described in Document No. 10 (Participating Authorities))

A detailed description of the goods and/or services that an Offeror will be required to supply for a Lot in which it has been successful is set out in the Offer Schedule (Document 06a(ii) and the Specification (Document No. 05).

Each National Product Code product Description listed in the Offer Schedule (Document No.06a(ii)), shall be a ‘Product’ for the purposes of this Invitation to Offer.

The tender comprises of the following offer schedule:

CM/PHG/12/5379/00

For each Product comprised in this offer schedule Offerors have the opportunity to bid for all (or any) of the three (3) Lots specified in paragraph 8.1 of Document No. 02 of the Invitation to Offer.

To ensure a diverse range of suppliers, in respect of each Product listed in the CM/PHG/12/5379/00 — Offer Schedule (Document No 06a(ii)) there is a restriction on the number of Lots that an Offeror can be awarded as follows:

Where 3 or more compliant offers that meet the qualitative criteria are received, a maximum of 1 Lot may be awarded to 1 supplier;

Where only 2 compliant offers that meet the qualitative criteria are received, a maximum of 2 Lots maybe awarded to 1 supplier;

Where only 1 compliant offer that meets the qualitative criteria is received, a maximum of all 3 Lots may be awarded to 1 supplier.

In respect of each Product in each Lot, unless otherwise notified, this procurement will establish a single supplier framework arrangement.

2)

Common Procurement Vocabulary (CPV)

33600000
33690000

3)

Quantity or scope


4)

Indication about different contract dates

 1-1-2017 31-12-2019

5)

Additional Information about lots

Information regarding lots is contained within the Invitation to Offer.


Coding

Commodity categories

ID Title Parent category
33600000 Pharmaceutical products Medical equipments, pharmaceuticals and personal care products
33690000 Various medicinal products Pharmaceutical products

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
sarah.blackman@dh.gsi.gov.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.